home / stock / crdl / crdl quote
Last: | $1.98 |
---|---|
Change Percent: | -1.04% |
Open: | $1.94 |
Close: | $1.98 |
High: | $2.02 |
Low: | $1.93 |
Volume: | 187,758 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.98 | $1.94 | $1.98 | $2.02 | $1.93 | 187,758 | 07-05-2024 |
$1.92 | $2 | $1.92 | $2 | $1.9 | 176,616 | 07-04-2024 |
$1.92 | $2 | $1.92 | $2 | $1.9 | 176,616 | 07-03-2024 |
$1.96 | $1.97 | $1.96 | $2.03 | $1.9 | 274,024 | 07-02-2024 |
$2 | $2.03 | $2 | $2.07 | $1.955 | 184,579 | 07-01-2024 |
$2.02 | $2.01 | $2.02 | $2.02 | $1.93 | 357,454 | 06-28-2024 |
$2 | $2.07 | $2 | $2.09 | $1.94 | 411,601 | 06-27-2024 |
$2.05 | $2.21 | $2.05 | $2.25 | $1.9942 | 585,920 | 06-26-2024 |
$2.12 | $2 | $2.12 | $2.202 | $1.95 | 726,406 | 06-25-2024 |
$2 | $1.91 | $2 | $2.1197 | $1.86 | 950,405 | 06-24-2024 |
$1.85 | $1.88 | $1.85 | $1.8933 | $1.785 | 306,158 | 06-21-2024 |
$1.89 | $2.01 | $1.89 | $2.0115 | $1.7 | 1,008,909 | 06-20-2024 |
$2.08 | $2.24 | $2.08 | $2.24 | $1.95 | 933,193 | 06-19-2024 |
$2.08 | $2.24 | $2.08 | $2.24 | $1.95 | 933,193 | 06-18-2024 |
$2.2 | $2.5 | $2.2 | $2.52 | $2.16 | 1,140,487 | 06-17-2024 |
$2.41 | $2.56 | $2.41 | $2.59 | $2.39 | 672,714 | 06-14-2024 |
$2.36 | $2.99 | $2.36 | $3 | $2.31 | 2,998,502 | 06-13-2024 |
$2.97 | $3 | $2.97 | $3.12 | $2.84 | 1,505,554 | 06-12-2024 |
$2.86 | $2.9 | $2.86 | $2.98 | $2.72 | 773,938 | 06-11-2024 |
$2.86 | $2.51 | $2.86 | $2.895 | $2.5091 | 1,849,595 | 06-10-2024 |
News, Short Squeeze, Breakout and More Instantly...
Cardiol Therapeutics Inc. Company Name:
CRDL Stock Symbol:
NASDAQ Market:
Cardiol Therapeutics Inc. Website:
Toronto, Ontario--(Newsfile Corp. - June 27, 2024) - Cardiol Therapeutics Inc. ( NASDAQ: CRDL ) ( TSX: CRDL ) (" Cardiol " or the " Company "), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatmen...
2024-06-26 06:30:06 ET B. Riley analyst issues BUY recommendation for CRDL on June 26, 2024 04:52AM ET. CRDL was trading at $2.12 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 2 - Buy recommendations . ...
Toronto, Ontario--(Newsfile Corp. - June 25, 2024) - Cardiol Therapeutics Inc. ( NASDAQ: CRDL ) ( TSX: CRDL ) (" Cardiol " or the " Company "), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatmen...